MedPath

SLK-Kliniken Heilbronn GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

Phase 1
Recruiting
Conditions
Advanced Renal Cell Carcinoma
Interventions
First Posted Date
2022-12-07
Last Posted Date
2022-12-07
Lead Sponsor
SLK Kliniken Heilbronn GmbH
Target Recruit Count
10
Registration Number
NCT05641545
Locations
🇩🇪

SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatologie, Onkologie, Palliativmedizin, Heilbronn, Germany

© Copyright 2025. All Rights Reserved by MedPath